More Time To Respond To CDRH Classification Reform Proposal
This article was originally published in The Gray Sheet
Executive Summary
Companies and other stakeholders will have an additional 90 days to comment on FDA’s proposed rule revising device classification policies. The proposal would add new regulation language to define high-risk class III devices, among other changes.